GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) » Definitions » Research & Development

Shenyang Xingqi Pharmaceutical Co (SZSE:300573) Research & Development : ¥230 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Shenyang Xingqi Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Shenyang Xingqi Pharmaceutical Co's Research & Development for the three months ended in Mar. 2025 was ¥47 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥230 Mil.


Shenyang Xingqi Pharmaceutical Co Research & Development Historical Data

The historical data trend for Shenyang Xingqi Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenyang Xingqi Pharmaceutical Co Research & Development Chart

Shenyang Xingqi Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.19 88.45 145.61 167.30 220.66

Shenyang Xingqi Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.07 40.63 60.78 81.18 47.07

Shenyang Xingqi Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥230 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenyang Xingqi Pharmaceutical Co  (SZSE:300573) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Shenyang Xingqi Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Shenyang Xingqi Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenyang Xingqi Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 68, Sishui Street, Dongling District, Liaoning Province, Shenyang, CHN, 110163
Shenyang Xingqi Pharmaceutical Co Ltd is a pharmaceutical company. It produces and sells opthalmic products. Its products include anti-bacterial products, corneal products, anti-inflammation products, anti-allergic, antifungal & among others.
Executives
Cheng Ya Nan Directors, executives
Gao E Directors, executives
Liu Ji Dong Directors, executives
Yang Qiang Director
Wang Shuo Securities Affairs Representative
Zhang Shao Yao Directors, Directors, and Executives

Shenyang Xingqi Pharmaceutical Co Headlines

No Headlines